Cite

    Chen, J. et al. (2023). Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2‐related factor 2‐mediated reactive oxygen species increment. Basic & clinical pharmacology & toxicology. 132 (3), pp. 253-262. [Online].